Results 1 to 10 of about 4,368 (70)

CD4 and CD20 as important immune markers in patients with pulmonary tuberculosis [PDF]

open access: yesE3S Web of Conferences, 2023
Tuberculosis (TB) is a serious lung infection caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) is highly contagious, and can be spread through the air from an infected person to others.
Kamoona Firas Mohammad Hussein   +1 more
doaj   +1 more source

Spontaneous Tumor Lysis Syndrome in a Patient with Mantle Zone Cell Lymphoma [PDF]

open access: yesLiaquat National Journal of Cancer Care, 2022
We describe the case of a patient diagnosed to have Mantle cell lymphoma (MCL), who underwent spontaneous tumor lysis syndrome, with overwhelming metabolic acidosis and acute kidney injury, was managed conservatively without the need for hemodialysis ...
Ikram A. Burney, Syed Azhar Rizvi
doaj   +1 more source

Non-Hodgkin lymphoma of cauda equina: A diagnostic conundrum: Case report

open access: yesAdvanced Biomedical Research, 2023
Primary central nervous system lymphoma (PCNSL) is uncommon with scarce cases having involvement of the spinal cord. Cauda equina is unique in its location and shows very rare involvement by diseases pathologies.
Pranati Misra   +5 more
doaj   +1 more source

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly.
Anisha Mohanpuria   +4 more
doaj   +1 more source

On the markers for schizophrenia

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2021
Summary. The study of various markers indicating an imbalance in both the neurotransmitter and immune systems observed in patients with schizophrenia is currently of great scientific and practical interest.
A. N. Erichev   +4 more
doaj   +1 more source

Ovarian Diffuse Large B-cell Lymphoma Initially Suspected Dysgerminoma Managed by Laparoscopic Staging Surgery

open access: yesGynecology and Minimally Invasive Therapy, 2020
Ovarian diffuse large B-cell lymphoma (DLBCL) is rare. DLBCL is a complex type of lymphoma. The ovarian DLBCL usually harbor a favorable prognosis. We report a case of ovarian DLBCL that presented as an ovarian mass with lower abdominal pain and was ...
Pei- Chen Li   +3 more
doaj   +1 more source

GAS5 Long Noncoding RNA Regulates CD20 Expression and Rituximab Response [PDF]

open access: yesAdvanced Pharmaceutical Bulletin
Purpose: Rituximab is the primary treatment for non-Hodgkin lymphoma (NHL), one of the most common cancers globally. One of the main challenges associated with rituximab therapy is the decline in its effectiveness over time.
Mahbubeh Rojhannezhad   +3 more
doaj   +1 more source

Neolymphogenesis and Immunogistogochemical Study of Lymph Nodes in Breast Cancer

open access: yesКреативная хирургия и онкология, 2020
Background. Our previous studies have shown that postnatally formed lymph nodes (PNFLN) can serve as a source of biological signals activating antitumour immune reactions and suppressing the spread of metastatic malignant cells.Aim.
Sh. Kh. Gantsev   +3 more
doaj   +1 more source

Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma

open access: yesAntibodies, 2022
This study aimed to investigate PD-L1 and PD-1 expression in circulating CD20+ cells in diffuse larger B-cell lymphoma (DLBCL) and to evaluate the predictive and diagnostic performance of PD-L1 versus PD-1 expression in circulating CD20+ cells in DLBCL ...
Manal Mohamed Saber
doaj   +1 more source

CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy

open access: yesOncoImmunology, 2018
Since tumors are often infiltrated by macrophages, it would be advantageous to turn these types of cells into cytotoxic effector cells. Here, we have designed a novel bispecific antibody (BsAb) that targets both tumor antigen (CD20) and the FcαRI ...
Bingyu Li   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy